Physician profile
William Michael Davis
NPI 1437195187
$9,215.92
in general payments reported to CMS, 2019-2025
22 companies · $1,408 in 2025
The $1,408 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $560 · 2020: $818 · 2021: $684 · 2022: $1,494 · 2023: $2,285 · 2024: $1,966 · 2025: $1,408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,659.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,843.90 | 2021-2025 | Corevalve Evolut R, Penditure |
| Medtronic Vascular, INC. | $1,122.14 | 2019-2020 | |
| Abbott Laboratories | $1,025.54 | 2019-2025 | Epic |
| Atricure, INC. | $1,020.12 | 2019-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System, Synergy Ablation System |
| Abiomed | $640.48 | 2023-2025 | Impella |
| Edwards Lifesciences Corporation | $279.52 | 2019-2022 | |
| Bolton Medical INC | $273.36 | 2020-2024 | Treo Abdominal Stent-Graft System |
| Corcym INC | $197.04 | 2022 | |
| Kls-Martin L.P. | $169.22 | 2022 | |
| Davol INC. | $133.01 | 2022 | |
| Medical Device Business Services, INC. | $124.99 | 2024 | Ethicon |
| Tela Bio, INC. | $76.06 | 2022 | |
| Innovation Technologies INC | $70.76 | 2024 | Irrisept |
| Access Pro Medical, LLC | $49.35 | 2023 | Matriderm |
| Mission Medical Distribution, LLC | $38.30 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $30.77 | 2024 | Perclot |
| Biotissue Holdings INC. | $28.34 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $22.08 | 2024 | |
| Lsi Solutions INC | $20.06 | 2021 | |
| Chiesi USA, INC. | $18.18 | 2023 | Cleviprex |
| Kerecis Limited | $16.95 | 2021 | |
| Pulmonx Corporation | $15.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.